Experimental combination is equivalent to standard care for prevention of GVHD Oncology Nurse Advisor Combining tacrolimus and sirolimus, both immunosuppressive compounds, did not provide a statistically significant, GVHD-free survival benefit over the long-used standard of care, which is tacrolimus plus methotrexate. The tacrolimus/sirolimus treatment ... |
